415 related articles for article (PubMed ID: 17803749)
41. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
[TBL] [Abstract][Full Text] [Related]
42. Cellular immunotherapy for cytomegalovirus and HIV-1 infection.
Van den Bosch GA; Ponsaerts P; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(2):107-21. PubMed ID: 16531812
[TBL] [Abstract][Full Text] [Related]
43. CMV infection after organ transplantation: immunopathological and clinical aspects.
The TH; Grefte JM; van der Bij W; van Son WJ; van den Berg AP
Neth J Med; 1994 Dec; 45(6):309-18. PubMed ID: 7838248
[TBL] [Abstract][Full Text] [Related]
44. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
Pescovitz MD
Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
[TBL] [Abstract][Full Text] [Related]
45. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A;
Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515
[TBL] [Abstract][Full Text] [Related]
46. CMV Infection in Bone Marrow and Solid Organ Transplant Patients in the Era of Antiviral Prophylaxis.
Hebart H; Jahn G; Sinzger C; Kanz L; Einsele H
Herpes; 2000 Feb; 7(1):13-17. PubMed ID: 11866995
[TBL] [Abstract][Full Text] [Related]
47. Monitoring human cytomegalovirus infection in transplant recipients.
Baldanti F; Lilleri D; Gerna G
J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients.
de Maar EF; Verschuuren EA; Harmsen MC; The TH; van Son WJ
Transpl Infect Dis; 2003 Sep; 5(3):112-20. PubMed ID: 14617298
[TBL] [Abstract][Full Text] [Related]
49. Assessing the economic merits of managing cytomegalovirus infection in organ and stem cell transplantation.
Wait S; Musingarimi P; Briggs A; Tillotson G
J Med Econ; 2009 Mar; 12(1):68-76. PubMed ID: 19450067
[TBL] [Abstract][Full Text] [Related]
50. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment.
Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V
J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702
[TBL] [Abstract][Full Text] [Related]
52. Primary cytomegalovirus infection in patients with Guillain-Barré syndrome.
Steininger C; Seiser A; Gueler N; Puchhammer-Stöckl E; Aberle SW; Stanek G; Popow-Kraupp T
J Neuroimmunol; 2007 Feb; 183(1-2):214-9. PubMed ID: 17184845
[TBL] [Abstract][Full Text] [Related]
53. Importance of CMV in the transplant population.
Rubin RH
Transpl Infect Dis; 1999; 1 Suppl 1():3-7. PubMed ID: 11565584
[TBL] [Abstract][Full Text] [Related]
54. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
[TBL] [Abstract][Full Text] [Related]
55. Immune response to CMV in solid organ transplant recipients: current concepts and future directions.
Watkins RR; Lemonovich TL; Razonable RR
Expert Rev Clin Immunol; 2012 May; 8(4):383-93. PubMed ID: 22607184
[TBL] [Abstract][Full Text] [Related]
56. Cytomegalovirus pneumonia in transplant recipients.
Ison MG; Fishman JA
Clin Chest Med; 2005 Dec; 26(4):691-705, viii. PubMed ID: 16263406
[TBL] [Abstract][Full Text] [Related]
57. Advances in understanding cytomegalovirus infection after transplantation.
Ho M
Transplant Proc; 1994 Oct; 26(5 Suppl 1):7-11. PubMed ID: 7940978
[TBL] [Abstract][Full Text] [Related]
58. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
59. Management of cytomegalovirus infection in solid organ transplantation.
Kotton CN
Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
[TBL] [Abstract][Full Text] [Related]
60. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
